Charles Winter
Hoofd Techniek/Wetenschap/O&O bij JANUX THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Charles Winter is currently the Chief Technical Officer at Janux Therapeutics, Inc. Prior to this, he worked as the Director of Biologics Development at Gilead Sciences, Inc. from 2011 to 2015, and as the Vice President of Manufacturing & Technology at Eden Biologics, Inc. from 2015 to 2016.
Winter received his undergraduate degree from the University of Wisconsin.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
JANUX THERAPEUTICS, INC.
-.--% | 02-01-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Charles Winter
Bedrijven | Functie | Begin |
---|---|---|
JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Eerdere bekende functies van Charles Winter
Bedrijven | Functie | Einde |
---|---|---|
JHL BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2016 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-06-2015 |
Opleiding van Charles Winter
University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
JANUX THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |